APA Submits Comments to the Drug Enforcement Administration (DEA)
The APA has submitted comments to the DEA on the two proposed rules around telemedicine prescribing of controlled substances (Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation & Expansion of Induction of Buprenorphine via Telemedicine Encounter). You may view the letters below.
APA letter to DEA – Telemedicine Prescribing
APA letter to DEA – Expansion of Induction of Buprenorphine via Telemedicine Encounter
Want to comment? There’s still time today to do so. It doesn’t have to be a treatise, just how this proposed rule could impact you and your patients.